Eisai Co - Company & Market Research Reports

Home /
Companies /
Eisai Co

Eisai Limited is a research-based pharmaceutical company that develops, manufactures, and markets healthcare products for patients and their families. It offers products in the areas of Alzheimer's disease, gastrointestinal disorders, epilepsy, cervical dystonia, severe chronic pain, and oncology. The company was founded in 1988 and is based in Hatfield, United Kingdom. It also has operations in the United States, Asia, and Europe.

REFINE BY

KEYWORD

CATEGORIES

Central Nervous System Drugs 122
Oncology Drugs 110
Drug Discovery 59
Gastrointestinal Drugs 54
Musculoskeletal Disorders Drugs 32
Clinical Trials 30
Pharmaceuticals 28
Alzheimer's Disease Drugs 28
Liver Cancer Drugs 27
Cardiovascular Drugs 21
Immune Disorders Drugs 21
Infectious Diseases Drugs 21
Brain Cancer Drugs 20
Breast Cancer Drugs 18
Leukemia Drugs 17
Biopharmaceuticals 17
Lymphoma Drugs 15
Endocrine and Metabolic Disorders Drugs 14
Drugs by Therapeutic Area 11
Infusions and Injectables 11
Anesthetic Drugs 11
Skin Cancer Drugs 11
Kidney Cancer Drugs 10
Analgesics 9
Hematological Drugs 9
Thyroid Cancer Drugs 9
Lung Cancer Drugs 8
Colon Cancer Drugs 8
Liver and Kidney Disorders Drugs 8
Ovarian Cancer Drugs 7
Bladder Cancer Drugs 7
Drug Delivery 7
Over the Counter (OTC) Drugs 7
Uterine Cancer Drugs 7
Vitamins and Dietary Supplements 7
Anti-Obesity Drugs 7
Pharmaceutical Manufacturing 7
Dermatological Drugs 6
Respiratory Drugs 5
Pharmaceutical Intermediates 4
Optical Disorders Drugs 4
Cervical Cancer Drugs 4
Mental Disorders Drugs 4
Company Reports 3
Pancreatic Cancer Drugs 3
Diabetes Drugs 2
Prostate Cancer Drugs 2
Biosimilars and Biosuperiors 2
Psoriasis Drugs 2
Sexual and Reproductive Health Drugs 2
Immunosuppressive Drugs 2
Generic Drugs 1
Pharmacoeconomics 1
Cough and Cold Drugs 1
Transdermal and Transmucosal Drug Delivery 1
Inhalers and Nebulisers 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



279 reviews

682 Results (Page 30 of 35)
- Relevance
  Sort by

Thrombocytopenia - Global Clinical Trials Review, 2025

 Clinical Trials
April 2025
915 Pages
Global

From

€3072EUR$3,450USD£2,663GBP

Hepatocellular Carcinoma - Opportunity Analysis and Forecasts to 2029

 Report
March 2021
214 Pages
Global

From

€9791EUR$10,995USD£8,486GBP

Arterial Thrombosis Drug Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

 Report
October 2024
81 Pages
Global

From

€3500EUR$4,210USD£3,140GBP

Oral Anticoagulant Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

 Report
September 2024
89 Pages
Global

From

€3500EUR$4,210USD£3,140GBP

Melanoma - Pipeline Review, H2 2020

 Drug Pipelines
November 2020
3809 Pages
Global

From

€2226EUR$2,500USD£1,929GBP

NEED HELP FINDING THE RIGHT PRODUCT? Olha will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Acute Repetitive Seizures Market - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, & Forecast 2023-2030 - (By Drug Type Coverage, Route of Administration Coverage, Distribution Channel Coverage, End-use Coverage, Geographic Coverage & Leading Companies)

 Report
October 2023
240 Pages
Global

€4270EUR$4,795USD£3,701GBP

Chagas Disease - Pipeline Insight, 2025

 Clinical Trials
April 2025
40 Pages
Global

From

€1113EUR$1,250USD£965GBP

Lewy Body Disease- Pipeline Insight, 2025

 Drug Pipelines
April 2025
60 Pages
Global

From

€1336EUR$1,500USD£1,158GBP

Dravet Syndrome- Pipeline Insight, 2025

 Clinical Trials
April 2025
60 Pages
Global

From

€1336EUR$1,500USD£1,158GBP

Anti-Epileptic Drugs Market: Analysis By Drug Generation, By Distribution Channel, By Region Size and Trends with Impact of COVID-19 and Forecast up to 2028

 Report
October 2023
159 Pages
Global

From

€2093EUR$2,350USD£1,814GBP

Intractable Focal Epilepsy Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2023-2030 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

 Report
August 2023
220 Pages
Global

€4092EUR$4,595USD£3,546GBP

HER2+ Breast Cancer - Global Drug Forecast and Market Analysis to 2030

 Report
September 2021
152 Pages
Global

From

€13353EUR$14,995USD£11,573GBP

Acute Myeloid Leukemia Therapeutics Global Market Insights 2022, Analysis and Forecast to 2027, by Manufacturers, Regions, Technology, Application, Product Type

 Report
March 2022
97 Pages
Global

From

€3500EUR$4,210USD£3,140GBP

Anti-epileptic Drugs Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2022 to 2030

 Report
August 2022
117 Pages
Global

From

€4007EUR$4,500USD£3,473GBP

Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2022 to 2030

 Report
August 2022
118 Pages
Global

From

€4007EUR$4,500USD£3,473GBP

Hepatic Encephalopathy Treatment Market Report and Forecast 2024-2032

 Report
February 2024
180 Pages
Global

From

€4425EUR$4,969USD£3,835GBP

Notch Receptor Antagonists - Pipeline Insight, 2025

 Drug Pipelines
April 2025
60 Pages
Global

From

€1336EUR$1,500USD£1,158GBP

Insomnia Therapies Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2022 To 2030

 Report
October 2022
119 Pages
Global

From

€4007EUR$4,500USD£3,473GBP

Non-Opioid Drugs for Chronic Pain and Pain Management Devices Market, 2018-2025

 Report
August 2018
340 Pages
Global

From

€3116EUR$3,499USD£2,700GBP

Alzheimer's Disease: Global Drug Forecast and Market Analysis to 2028

 Report
May 2020
218 Pages
Global

From

€13353EUR$14,995USD£11,573GBP

682 Results (Page 30 of 35)
- 1
- 28
- 29
- 30
- 31
- 32

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.